Medicare Benefits Schedule - Item 73447

Search Results for Item 73447

View Associated Notes

Category 6 - PATHOLOGY SERVICES

73447

73447 - Additional Information

Item Start Date:
01-Nov-2023
Description Updated:
01-Nov-2023
Schedule Fee Updated:
01-Nov-2023

Group
P7 - Genetics

Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin

Applicable once per diagnostic episode, at diagnosis, disease progression or relapse

Fee: $927.90 Benefit: 75% = $695.95 85% = $829.20

(See para PN.7.14 of explanatory notes to this Category)

Associated Notes

Category 6 - PATHOLOGY SERVICES

PN.7.14

Note for haematological malignancy gene panel tests

Testing should include, but not be restricted to, genes described in the current World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms or other appropriate international guidelines.

 

Related Items: 73445 73446 73447 73448

Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change